# What are induced pluripotent stem cells?

> Written with AI · [Biotechnology: stem cells and regenerative medicine](https://lessoons.com/en/stem-cells-and-regenerative-medicine) · Grade 12 · 2026-11-13 · https://lessoons.com/en/stem-cells-and-regenerative-medicine/what-are-induced-pluripotent-stem-cells

Induced pluripotent stem cells, iPS cells, are adult cells, such as skin cells, reprogrammed in the laboratory into a state like that of embryonic stem cells, able to become almost any cell type of the body. In 2006 Shinya Yamanaka's team did it by switching on four genes, and the discovery shared the 2012 Nobel Prize in Physiology or Medicine.

## The topic explained

### Turning back a cell's clock

What are induced pluripotent stem cells? Every cell of the body carries the same genes, but a skin cell keeps only the skin genes switched on, and for decades a specialized cell was thought to stay specialized. A cell that can still become any cell type is pluripotent. Until 2006 the only such cells grown in the laboratory were embryonic stem cells, taken from an early embryo, which destroyed it and raised a long ethical debate.

In 2006 Kazutoshi Takahashi and Shinya Yamanaka in Kyoto tested 24 genes active in embryonic stem cells and found that four, Oct3/4, Sox2, Klf4 and c-Myc, were enough to return mouse skin cells to a pluripotent state. They called the result induced pluripotent stem cells, iPS cells, and a year later did the same with adult human cells. In 2012 Yamanaka shared the Nobel Prize in Physiology or Medicine with John Gurdon, whose experiments decades earlier had shown that the nucleus of an adult cell can still make a whole animal.

### How reprogramming works

The four genes code for transcription factors, proteins that switch other genes on and off. Delivered into adult cells, they switch on the network of genes that keeps a cell pluripotent and help switch off the genes of the skin. After several weeks in culture, a small share of the cells form colonies that look and behave like embryonic stem cells. They are tested by checking which genes they use and by letting them become many cell types. The process is slow and inefficient: most cells that receive the factors never become pluripotent, which is why colonies are picked out and checked one by one.

A common misreading is that the four factors build new organs or make a cell young again in every way. They only reset which genes are active; it is the later steps, guided by other signals, that turn iPS cells into nerve, heart or retina cells.

### What they are used for

Because iPS cells can come from anyone, they carry that person's genes. Cells from a person with an inherited condition can be grown into the affected cell type, such as nerve or heart cells, to study the condition in a dish and to test candidate medicines, a use called disease modeling. Heart cells grown from iPS cells are also used in laboratories, alongside other tests, to check whether candidate medicines disturb heart cells. On 12 September 2014, a team led by Masayo Takahashi at the RIKEN institute in Japan transplanted a sheet of retina cells made from a patient's own skin cells into the eye of a woman in her seventies with age-related macular degeneration, the first transplant of cells made from iPS cells.

### Risks, and the questions they raise

The cells carry real risks, studied in every trial. c-Myc is an oncogene, a gene linked to cancer, and pluripotent cells left in a transplant can grow into tumors, so newer methods avoid c-Myc and remove every undifferentiated cell. Cells can also gain genetic changes in culture: the 2014 trial was paused before a second patient was treated after such changes were found in that patient's cells, and later work used cells from donors. iPS cells avoid destroying embryos, which answered one ethical objection, but they raise others, such as who controls a person's cells and how fast unproven treatments should reach patients. Any decision about treatment belongs to doctors and approved clinical trials.

## Practice: induced pluripotent stem cells

For 12th grade biotechnology students. Answer each question from the sheet, then check your answers.

1. **Define a pluripotent cell, and say what is induced about iPS cells.** — A cell that can become almost any cell type of the body. iPS cells are induced because adult cells are made pluripotent in the laboratory, by switching on four genes.
2. **Fill in step 2 and name the four genes used in 2006.** — Add four gene-regulating factors: Oct3/4, Sox2, Klf4 and c-Myc.
3. **What do the four genes code for, and how does that reprogram a cell?** — Transcription factors, proteins that switch other genes on and off. They switch on the gene network of pluripotent cells and help switch off the genes of the specialized cell.
4. **Complete the hidden row and explain why it mattered in the ethical debate.** — Embryonic stem cells: yes, an embryo is destroyed; iPS cells: no. Objections to destroying embryos were a main argument against embryonic stem cell research, and iPS cells avoid it.
5. **Fill in the third cell type and explain why cells grown from one person's iPS cells are useful for studying that person's inherited condition.** — Retina cells. They carry the person's own genes, so the condition can be studied in the affected cell type in a dish, and candidate medicines tested on it.
6. **Name two risks of using cells made from iPS cells in patients.** — Tumors, from leftover pluripotent cells or the oncogene c-Myc, and genetic changes gained while the cells grew in culture.
7. **What did John Gurdon's earlier work show, and why was he honored with Yamanaka?** — That the nucleus of a specialized adult cell can still direct the making of a whole animal, so specialization does not erase genes. Yamanaka showed how to reset such a cell directly, so the two discoveries answer the same question.

## Common questions

### What is the difference between iPS cells and embryonic stem cells?

Both are pluripotent. Embryonic stem cells come from an early embryo, which is destroyed; iPS cells are made from adult cells, so no embryo is needed and they can carry the donor's own genes.

### What are the Yamanaka factors?

The four transcription factors Oct3/4, Sox2, Klf4 and c-Myc, which Takahashi and Yamanaka used in 2006 to reprogram adult mouse cells into iPS cells.

### Are iPS cell treatments available?

Treatments made from iPS cells are being tested in clinical trials for a few conditions. Whether a treatment is approved and suitable for anyone is decided by regulators and doctors, not by clinics advertising it.

### Can iPS cells be made from blood?

Yes. Besides skin cells, researchers reprogram cells from blood and other tissues, and the choice depends on what is easiest to collect and grow.

### Why is c-Myc a concern?

c-Myc is an oncogene, a gene that can drive cancer when overactive, so many newer methods reprogram cells without it to lower the risk of tumors.
